The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
31 | 7 | 70 | 50 |
Growth
|
69 | 84 | 45 | 47 |
Safety
|
52 | 52 | 78 | 80 |
Sentiment
|
41 | 37 | 12 | 39 |
|
32 | 32 | 38 | 33 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
31 | 35 | 19 | 5 |
Opinions Change
|
67 | 50 | 50 | 50 |
Pro Holdings
|
n/a | 33 | 50 | 71 |
Market Pulse
|
78 | 46 | 15 | 60 |
Sentiment
|
41 | 37 | 12 | 39 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
31 | 7 | 70 | 50 |
Growth
|
69 | 84 | 45 | 47 |
|
52 | 52 | 78 | 80 |
Combined
|
40 | 42 | 85 | 57 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
4 | 4 | 4 | 4 |
Price vs. Earnings (P/E)
|
59 | 27 | 83 | 68 |
Price vs. Book (P/B)
|
24 | 8 | 79 | 45 |
Dividend Yield
|
1 | 1 | 1 | 1 |
Value
|
31 | 7 | 70 | 50 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
94 | 86 | 1 | 94 |
Profit Growth
|
24 | 84 | 88 | 6 |
Capital Growth
|
91 | 6 | 79 | 81 |
Stock Returns
|
23 | 100 | 43 | 1 |
Growth
|
69 | 84 | 45 | 47 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
100 | 100 | 100 | 92 |
Refinancing
|
69 | 45 | 87 | 77 |
Liquidity
|
1 | 1 | 4 | 4 |
|
52 | 52 | 78 | 80 |
Discover high‑ranked alternatives to Clover Health Investments and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.